StockWatch
·

Medpace Holdings, Inc. Q3 FY25 Results

MEDPQ3 FY25 Results
Filing
MetricValue ($ M)Q2 FY25Q3 FY24
Revenue659.909.4%23.7%
Total Income659.909.4%23.7%
Expenditure518.108.6%23.1%
PBT142.8414.7%20.3%
Net Profit111.1423.1%15.3%
OPM21.49%0.55pp0.44pp
NPM16.84%1.88pp1.24pp
EPS3.9525.0%27.0%
View full financials

Company Announces Financial Results for September 30, 2025

04 May 2026 · 4 May, 8:54 am

Summary

The Company issued a press release announcing its financial results for the three and nine months ended September 30, 2025. The full text of the press release was posted on the Company’s internet website and is furnished as Exhibit 99.1. The information contained in the press release is furnished and shall not be deemed “filed”.

Informational and educational content only. Not investment advice.